Viewing Study NCT02126033


Ignite Creation Date: 2025-12-25 @ 2:52 AM
Ignite Modification Date: 2026-03-02 @ 4:00 PM
Study NCT ID: NCT02126033
Status: UNKNOWN
Last Update Posted: 2014-04-29
First Post: 2014-04-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Telomeres Parameters in Celiac Disease
Sponsor: Meir Medical Center
Organization:

Study Overview

Official Title: None
Status: UNKNOWN
Status Verified Date: 2014-04
Last Known Status: NOT_YET_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Celiac disease is an autoimmune process that causes destructive changes in the epithel of the small bowel and it is also a pre-malignant state (e.g lymphoma). The aim of the study is to examine telomere length and other parameters of genetic instability from peripheral blood lymphocytes of patients with celiac disease compared with healthy controls.
Detailed Description: None

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: